INHIBITION OF THE LEUKEMOGENICITY OF MYELOID LEUKEMIC CELLS IN MICE AND IN VIVO INDUCTION OF NORMAL DIFFERENTIATION OF THE

Size: px
Start display at page:

Download "INHIBITION OF THE LEUKEMOGENICITY OF MYELOID LEUKEMIC CELLS IN MICE AND IN VIVO INDUCTION OF NORMAL DIFFERENTIATION OF THE"

Transcription

1 INHIBITION OF THE LEUKEMOGENICITY OF MYELOID LEUKEMIC CELLS IN MICE AND IN VIVO INDUCTION OF NORMAL DIFFERENTIATION OF THE Mikio TOMIDA, Yuri YAMAMOTO, and Motoo HOZUMI Department of Chemotherapy, Saitama Cancer Center Research Institute* The effects of synthetic RNAs on the leukemogenicity of mouse myeloid leukemic M1 cells were studied in syngeneic SL mice. M1 cells are known to be capable of differentiating into macrophages and granulocytes both in vitro and in vivo. Mice that had been inoculated with three different clones (T-22, R-4 and DR-3) of M1 cells varying in sensitivity to inducers of differentiation died 20 to 40 days after inoculation. However, 10 out of 14 mice inoculated with the slightly prolonged the survival times of mice inoculated with some clones of M1 cells. lating activity, which induced differentiation of M1 cells in vitro, were markedly induced within 3hr in the serum of the mice. cells was examined by implanting diffusion chambers containing the cells into syngeneic SL strain mice. The in vivo inductions of differentiation of three clones (T-22, R-4 and DR-3) of M1 cells in untreated mice varied, but all three clonal cells showed marked differentiation into macrophages and granulocytes in mice These results suggest that stimulation of induction of normal differentiation and interferon to the leukemic cells and immunopotentiating activity of the RNA may also be involved. differentiation-leukemogenicity Mouse myeloid leukmic M1 cells can be induced to differentiate into macrophages and granulocytes both in vitro15,16) and in vivo,8,20,25) and various inducers of in vitro differentiation of M1 cells are known.13,27) A protein inducer(s), designated as D-factor (differentiation-stimulating factor)11,12,22) or MGI (macrophage and granulocyte inducer),27) was found in conditioned media of various cultured cells,14,15,22,29) ascitic serum.4) Macrophages and granuloctyes were suggested to be mainly responsible for the production of D-factor.11,12,15) We previously showed that double-stranded RNAs

2 duction of D-factor by mouse peritoneal macrophages in vitro.29) Furthermore, we found that these RNAs directly affect M1 cells, making them more sensitive to D- factor.32) These RNAs did not themselves induce differentiation of M1 cells, but they markedly stimulated the induction by a low concentration of D-factor. The effect of these RNAs was concluded to be mediated by induced interferon,32) because the RNAs also induced interferon in M1 cells, because partially purified interferon had a stimulatory effect on the differentiation of M1 cells and because the stimulatory effect of the RNAs was abolished by simultaneous treatment of the M1 cells with anti-interferon serum. On the other hand, it was shown that differentiated M1 cells induced in vitro could no longer develop into tumors in syngeneic SL strain mice.5,16) Honma et al.8) also reported a correlation between leukemogenicity and in vivo inducibility of differentiation in several clones of M1 cells. Therefore, we tried to inhibit the development of M1 cell leukemia in syngeneic SL mice by enhancing the induction of normal differentiation of the cells with synthetic RNAs. MATERIALS AND METHODS Animals About 60-day-old, specific pathogenfree SL strain mice maintained in this laboratory were used throughout. Cells Myeloid leukemic M1 cells were originally obtained from a spontaneous myeloid leukemia in an SL strain mouse.15) Clone T-22 cells29) can be induced to differentiate into macrophages and granulocytes by inducers such as D-factor or glucocorticoid hormones. Clone R-424) and DR- 37) cells, which cannot be induced to differentiate in vitro by inducers alone, were also isolated from M1 cells. The cells were cultured in Eagle's minimal essential medium (Nissui Seiyaku Co., Tokyo), supplemented with double the usual concentrations of amino acids and vitamins and M. TOMIDA, ET AL. Culture of Cells in Diffusion Chambers The chambers were made from Millipore mem- scribed previously,2,8) and 0.1ml of cell suspension into each one. Two chambers were implanted into the peritoneal cavity of each mouse that had received no pretreatment. The cells were collected after 4 days by processing the chambers in 0.5% pronase and 5% Ficoll-400 in Hanks' balanced with May-Grunwald-Giemsa stain. More than 200 cells from each chamber were analyzed for the determination of morphological differentiation. Assay of Interferon Interferon in mouse serum was assayed by determining the inhibition of 3H-uridine incorporation into vesicular stomatitis virus RNA in L cells by the method of Kawade et al.17) In this work titers of interferon were measured with NIH reference standard mouse interferon (Cat. No., G ) as a standard and are expressed in international reference units (IU). Assay of D-factor Activity of D-factor in mouse serum was assayed by measuring the induction of phagocytic activity in M1 cells by the serum. M1 (T-22) cells were incubated with various concentrations of the serum for 2 days and then their phagocytic activity was assayed as described previously,29) using polystyrene latex poly(u) and poly(i) were obtained from Yamasa Shoyu, Choshi. RESULTS Effects of Treatment with Synthetic RNAs on the Survival of Mice Inoculated with Various Clones of M1 Cells We inoculated ip 105 cells of three different clones of M1 cells into SL mice. As shown in Fig. 1, all the mice inoculated with T-22 clonal cells, which could be induced to differentiate in vitro by inducers such as D- factor and glucocorticoid, died 29 to 40 days after inoculation. Mean survival times of mice inoculated with R-4 and DR-3 clonal cells, which were less sensitive to inducers, tively. The difference in leukemogenicity between sensitive T-22 cells and resistant R-4 and DR- 3 cells is significant (P<0.001). Honma et al.8) previously showed a clear difference in Gann

3 Fig, 1. Effects of synthetic RNAs on the survival EFFECT OF POLY I:C ON MYELOID LEUKEMIA times of mice inoculated with M1 cells Clone T-22 (a), R-4 (b) or DR-3 (c) cells at 105 cells per 0.2ml of phosphate-buffered saline were inoculated ip into SL mice. Synthetic RNAs in 0.2ml of phosphatebuffered saline were injected ip at the time of cell inoculation and then twice a week until day 93. Groups of leukemogenicity between the resistant and the sensitive cells with a smaller inoculum size (104 cells/mouse). poly(u) and poly(i) were injected ip at the time of cell inoculation and then twice weekly at doses that were not toxic to the mice. Survival of mice inoculated with each clone of M1 cells was markedly prolonged out of 5 mice inoculated with T-22 cells, 3 out of 5 mice inoculated with R-4 cells and 3 out of 4 mice inoculated with DR-3 cells survived for more than 100 days. Three and one of the survivors inoculated with DR-3 cells and R-4 cells, respectively, died of leu- (125 days from the first treatment) with killed at day 165. mouse) for the suppression of leukemia. A similar difference in the effectiveness of the leukemic cells was observed in vitro: a 50- to 100-fold higher concentration of poly quired for the induction of interferon and stimulation of differentiation of T-22 cells.32) We previously showed that T-22 clone cells, but not R-4 or DR-3 clone cells, were induced to differentiate in vitro by treatment days.30) Therefore, we expected an inhibitory effect of poly(i) on the leukemogenicity of the sensitive T-22 cells. The mean survival time of mice injected with T-22 cells Induction of Interferon and Differentiation-stimulating Activity in Mouse feron. We have found that interferon stimulated the induction of differentiation of M1 cells by D-factor (Cancer Res., in press), poly(c) enhanced the production of D- factor in mouse peritoneal macrophages in vitro.29) Hence, we examined the effect of feron and D-factor in vivo. As shown in Fig. 2, the activities of interferon and D-factor were not detectable in the serum of untreated mice (0 time), but both activities were induced within 3hr af- gradually decreased. Interferon disappeared

4 M. TOMIDA, ET AL. induction of differentiation of M1 cells M1 cells were cultured in diffusion chambers in SL of the diffusion chambers. Fig. 2. Activities of interferon and D-factor in Serum was collected from 3 mice at the indicated times and pooled. Activities of interferon and D-factor in the sera were assayed as described in "Materials and Methods." Activity of D-factor was assayed with 1% more rapidly than the differentiation-stimulating activity. Significant activity of D- factor remained for 72hr after treatment Induction of Differentiation of M1 Cells In vivo induction of differentiation of cells was demonstrated by the diffusion chamber technique.8,20,25) In untreated mice, the induction of differentiation of M1 cells was correlated with the in vitro sensitivity of the cells to inducers such as D-factor and dexamethasone. As shown in Fig. 3, T-22 cells, but not R-4 or DR-3 cells, were induced to differentiate into mature macrophages and granulocytes within 4 days after their implan- poly(c) into the mice, even resistant R-4 and DR-3 cells were induced to differentiate (Fig. 4), and differentiation of the sensitive T-22 cells was significantly stimulated. DISCUSSION We clearly demonstrated that injection times of mice inoculated with myeloid leukemic M1 cells and stimulated in vivo induction of differentiation of the cells. The mechanisms of inhibition of leukemogenicity known, but stimulation of the normal differentiation of the leukemic cells seems to be Gann

5 EFFECT OF POLY I:C ON MYELOID LEUKEMIA

6 one of the mechanisms, since it was shown that, on differentiation in vitro, M1 cells lose both proliferating activity and leukemogenicity,5,16) and that the leukemogenicity of each clone of M1 cells is inversely correlated with its in vivo inducibility of differentiation.8) Furthermore, leukemogenicity of M1 cells was recently shown9) to be inhibited by the injection into mice of inducers (lipopolysaccharide31) and dexamethasone) of differentiation of the cells. In the present paper, we showed that M. TOMIDA, ET AL. suited in the induction of D-factor activity and interferon in their sera. Lotem and Sachs21) and we found that an appropriate concentration of interferon stimulated the induction of differentiation of M1 cells by a low concentration of D-factor in vitro (Cancer Res., in press). Therefore, stimulation of in vivo induction of differentiation of M1 cells Lion of D-factor and interferon by the RNA. Although we observed stimulation by activity of macrophages1,28) and natural killer cells.3) Therefore, these various actions ferentiation of M1 cells, including clones which were resistant to inducers in vitro, no definitive correlation was observed between the differentiation of the cells and the survival times of the leukemic mice (Figs. 1 and 3). T-22 cells could differentiate into macrophages and granulocytes in untreated mice to almost the same degree that DR-3 cells most resistant to treatment with the RNA mice. However, mice injected with DR-3 examine myeloid leukemia. To our knowl- better than those that received T-22 cells alone. Therefore, stimulation of the induction poly(c) is not the only mechanism of inhibition of leukemogenicity of the cells by the RNA. One possible mechanism involved may be kemic cells. Treatment of T-22 cells with 5 ug/ml of the RNA in vitro for 2 days reduced DR-3 cells could tolerate even 1mg/ml of the RNA (85 and 95% of the growth of controls, respectively). Therefore, a direct cytotoxic effect of the RNA on T-22 cells may contribute to the prolongation of the survival times of mice inoculated with these cells. Although a difference in the antigenicity of each clone of the M1 cells against syngeneic SL mouse may also affect the leukemogenicity of the cells through immune mechanisms, no such difference in antigenicity was detected among the clones.9) Another possible mechanism of inhibition of the leukemogenicity of the leukemic cells is suppression of growth of the cells by interferon induced by the RNA. Suppression by interferon of in vitro growth of M1 cells was recently observed. Unexpectedly, the resistant clones, R-4 and DR-3, were more sensitive to interferon than the sensitive clones, T-22. recently reported to stimulate the tumoricidal of interferon may also be involved in the (C) of the leukemogenicity of M1 cells. On the other hand, antitumor effects of various tumors. Although Levy et al.19) reported that lymphatic leukemias were the among various tumors of mice, they did not poly(c) markedly inhibits myeloid leukemia. clinically useful26) because of its rapid hydrolysis by nuclease in primate serum.23) Recently, a stabilized material consisting of poly(c) complex may be useful for the therapy of some patients with myeloid leukemia. Gann

7 EFFECT OF POLY I:C ON MYELOID LEUKEMIA This work was supported in part by Grantsin-Aid for Cancer Research from the Ministry of Health and Welfare, and from the Ministry of Education, Science and Culture. (Received January 23, 1980) 14) Hozumi, M., Umezawa, T., Takenaga, K., Ohno, T., Shikita, M., Yamane, I., Cancer 17) Kawade, Y., Matsuzawa, T., Yamamoto, Y., Tsukui, K., Iwakura, Y., Annu. Rep. 18) Levy, H. B., Baer, G., Baron, S., Buckler, C. E., Gibbs, C. J., Iadarola, M. J., London, 10) Hozumi, M., Sugiyama, K., Mura, M., Takizawa, H., Sugimura, T., Matsushima, T., Ichikawa, Y., Proc. 4th Int. Symp. Princess 12) Hozumi, M., Honma, Y., Okabe, J., Tomida, M., Kasukabe, T., Takenaga, K., Sugiyama, K., "Oncogenic Viruses and Host Cell Genes," ed. Y. Ikawa and T. 13) Hozumi, M., Honma, Y., Tomida, M., Okabe, J., Kasukabe, T., Sugiyama, K., Hayashi, M., Takenaga, K., Yamamoto,

[GANN, 62, ; April, 1971]

[GANN, 62, ; April, 1971] [GANN, 62, 139-143; April, 1971] UDC 576.8.097.3:547.854 EVALUATION OF CELL DAMAGE IN IMMUNE REACTIONS BY RELEASE OF RADIOACTIVITY FROM 3H-URIDINE LABELED For quantitative evaluation of cell damage in

More information

Sensitized Mice. cells (Japan strain, Japan BCG Co., Tokyo) were. grown in Dubos broth medium (Difco Laboratories,

Sensitized Mice. cells (Japan strain, Japan BCG Co., Tokyo) were. grown in Dubos broth medium (Difco Laboratories, INFECTION AND IMMUNITY, June 1982, p. 966-970 0019-9567/82/060966-05$02.00/0 Vol. 36, No. 3 Induction of Alpha and Beta Interferons During the Hyporeactive State of Gamma Interferon by Mycobacterium bovis

More information

Interferon Immunosuppression: Mediation by a Suppressor

Interferon Immunosuppression: Mediation by a Suppressor INFECTION AND IMMUNITY, Aug. 1980, p. 301-305 0019-9567/80/08-0301/05$02.00/0 Vol. 29, No. 2 Interferon Immunosuppression: Mediation by a Suppressor Factor HOWARD M. JOHNSON* AND J. EDWIN BLALOCK Department

More information

Cultural Characteristics of a Cell Line Derived

Cultural Characteristics of a Cell Line Derived APPLIED MICROBIOLOGY, Nov. 1972, p. 727-731 Copyright 1972 American Society for Microbiology Vol. 24, No. 5 Printed in U.S.A. Cultural Characteristics of a Cell Line Derived from an Equine Sarcoid R. E.

More information

Interferon-Producing Capacity of Germfree Mice

Interferon-Producing Capacity of Germfree Mice INFECTION AND IMMUNrrY, Feb. 1976, p. 332-336 Copyright 1976 American Society for Microbiology Vol. 13, No. 2 Printed in USA. Interferon-Producing Capacity of Germfree Mice YASUHIKO ITO, YUKIHIRO NISIYAMA,

More information

Immune enhancement by increased number of B-cells

Immune enhancement by increased number of B-cells Page 1 of 6 Immune enhancement by increased number of B-cells - A summary report of scientific studies with GlycaNova s beta-glucan, Lentinex Background Human immunity can be divided in two main parts,

More information

ELECTRON-MICROSCOPIC OBSERVATIONS OF POLYOMA VIRUS-TRANSFORMED MOUSE CELLS TREATED WITH SPECIFIC IMMUNE SERUM

ELECTRON-MICROSCOPIC OBSERVATIONS OF POLYOMA VIRUS-TRANSFORMED MOUSE CELLS TREATED WITH SPECIFIC IMMUNE SERUM J. Cell Sci. 7, 711-718(1970) 7II Printed in Great Britain ELECTRON-MICROSCOPIC OBSERVATIONS OF POLYOMA VIRUS-TRANSFORMED MOUSE CELLS TREATED WITH SPECIFIC IMMUNE SERUM G.NEGRONI AND RITA TILLY Department

More information

Agent. line of mouse L-cell fibroblasts (L929), originally obtained from the American Type Culture Collection Cell Repository.

Agent. line of mouse L-cell fibroblasts (L929), originally obtained from the American Type Culture Collection Cell Repository. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1972, p. 73-78 Copyright 1972 American Society for Microbiology Vol. 2, No. 2 Printed in U.S.A. Tilorone Hydrochloride: an Oral Interferon-Inducing Agent DALE

More information

Transfer Agent of Immunity. VI. Serial Passive Transfers of Cellular Immunity to Salmonella Infection by Immune Ribonucleic Acid

Transfer Agent of Immunity. VI. Serial Passive Transfers of Cellular Immunity to Salmonella Infection by Immune Ribonucleic Acid Japan. J. Microbiol. Vol. 15 (2), 159-168, 1971 Transfer Agent of Immunity VI. Serial Passive Transfers of Cellular Immunity to Salmonella Infection by Immune Ribonucleic Acid Kazuko SAITO, Nobutaka OSAWA,

More information

Nature Biotechnology: doi: /nbt.4086

Nature Biotechnology: doi: /nbt.4086 Ag (-) anti-cd3 p815 p815-hcd2 Ag (-) anti-cd3 p815 p815-hcd2 Ag (-) anti-cd3 p815 p815-hcd2 Ag (-) anti-cd3 p815 p815-hcd2 Ag (-) anti-cd3 p815 p815-hcd2 Ag (-) anti-cd3 p815 p815-hcd2 Ag (-) anti-cd3

More information

Convoy TM Transfection Reagent

Convoy TM Transfection Reagent Convoy TM Transfection Reagent Catalog No.11103 0.25ml (40-80 transfections in 35mm dishes) Catalog No.11105 0.5 ml (80-165 transfections in 35mm dishes) Catalog No.11110 1.0 ml (165-330 transfections

More information

IMMUNIZATION AGAINST EHRLICH MOUSE ASCITES CARCINOMA WITH CHEMICALLY DEVITALIZED TUMOR CELLS *

IMMUNIZATION AGAINST EHRLICH MOUSE ASCITES CARCINOMA WITH CHEMICALLY DEVITALIZED TUMOR CELLS * IMMUNIZATION AGAINST EHRLICH MOUSE ASCITES CARCINOMA WITH CHEMICALLY DEVITALIZED TUMOR CELLS * MASAHIRO YOSHIMURA AND TOSHIKO KABURAKI Department of Pharmacology, Research Institute of Tuberculosis, Kanazawa

More information

PARTIALLY PURIFIED LENTINAN FROM SHIITAKE MUSHROOM (LENTINUS EDODES) STILL RETAIN ANTITUMOUR ACTIVITY

PARTIALLY PURIFIED LENTINAN FROM SHIITAKE MUSHROOM (LENTINUS EDODES) STILL RETAIN ANTITUMOUR ACTIVITY -------The 3 rd ICMBMP October 1999 PARTIALLY PURIFIED LENTINAN FROM SHIITAKE MUSHROOM (LENTINUS EDODES) STILL RETAIN ANTITUMOUR ACTIVITY Ann-Teck Yap, Sudhir Kumar Chandramohan, Mah-Lee Ng Mary Department

More information

The flow diagram below shows part of a process to produce a protein, using genetically modified plants.

The flow diagram below shows part of a process to produce a protein, using genetically modified plants. 1 Some organisms have been genetically modified to produce proteins including hormones and vaccines. The flow diagram below shows part of a process to produce a protein, using genetically modified plants.

More information

antigen." 2 Moreover, when mixed populations of normal and sensitive cells

antigen. 2 Moreover, when mixed populations of normal and sensitive cells DELA YED HYPERSENSITIVITY IN VITRO: ITS MEDIATION BY CELL-FREE SUBSTANCES FORMED BY LYMPHOID CELL-ANTIGEN INTERACTION* BY JOHN R. DAVIDt DEPARTMENT OF MEDICINE, NEW YORK UNIVERSITY SCHOOL OF MEDICINE Communicated

More information

ICH CONSIDERATIONS Oncolytic Viruses

ICH CONSIDERATIONS Oncolytic Viruses European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ICH CONSIDERATIONS Oncolytic Viruses 20 November 2008 EMEA/CHMP/GTWP/607698/2008

More information

Supplementary Methods Antibodies for flow cytometry Cytotoxicity assay

Supplementary Methods Antibodies for flow cytometry Cytotoxicity assay Supplementary Methods Antibodies for flow cytometry HLA-Cw3 and CD2 expression: LCL 72.22 cell lines were stained with anti-hla-abc-apc (clone G46-2.6, BD) or migg-apc (clone MOPC-2, BD) antibody, or with

More information

Chapter 14. Second symmetry

Chapter 14. Second symmetry Chapter 14. Second symmetry Tyger Tyger, burning bright In the forests of the night What immortal hand or eye Could frame thy fearful symmetry? -William Blake Songs of Experience (1794) A good general

More information

UNIVERSITY OF TEXAS AT ARLINGTON INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE MONOCLONAL ANTIBODIES/MOUSE ASCITES SOP

UNIVERSITY OF TEXAS AT ARLINGTON INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE MONOCLONAL ANTIBODIES/MOUSE ASCITES SOP UNIVERSITY OF TEXAS AT ARLINGTON INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE MONOCLONAL ANTIBODIES/MOUSE ASCITES SOP A. PRODUCTION OF MONOCLONAL ANTIBODIES IN MOUSE ASCITES FLUID 1. Introduction: a. Monoclonal

More information

obtained from the infected and treated tissues, Fleming's2 technic of hemolytic streptococcus B. Immediately following the infection, 1.0 ml.

obtained from the infected and treated tissues, Fleming's2 technic of hemolytic streptococcus B. Immediately following the infection, 1.0 ml. THE SENSITIVITY OF STREPTOCOCCI TO PENICILLIN G AFTER EXPOSURE TO THE ANTIBIOTIC IN VIVO* E. GRUNBERG, C. UNGER, AND D. ELDRIDGE Previous investigations by Grunberg, Schnitzer, and Unger3 on the topical

More information

Tumor-Associated Transplantation Antigens in Immune Rejection of Mouse Malignant Cell Hybrids

Tumor-Associated Transplantation Antigens in Immune Rejection of Mouse Malignant Cell Hybrids Proc. Nat. Acad. Sci. USA Vol. 72, No. 6, pp. 2130-2134, June 1975 Tumor-Associated Transplantation Antigens in Immune Rejection of Mouse Malignant Cell Hybrids (analysis of malignancy/cell surface antigens/cytotoxicity)

More information

ICH Considerations. Oncolytic Viruses September 17, 2009

ICH Considerations. Oncolytic Viruses September 17, 2009 INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH Considerations Oncolytic Viruses September 17, 2009 1. Introduction Oncolytic viruses

More information

A Sex-Limited Serum Protein Variant in the Mouse: Hormonal Control of Phenotypic Expression

A Sex-Limited Serum Protein Variant in the Mouse: Hormonal Control of Phenotypic Expression Biochemical Genetics 5:201-209 (1971) A Sex-Limited Serum Protein Variant in the Mouse: Hormonal Control of Phenotypic Expression Howard C. Passmore 1 and Donald C. Shreffier 1 Received 2 Oct. 1970-Final

More information

Autocrine Complement Inhibits IL10-Dependent T-Cell Mediated. Antitumor Immunity to Promote Tumor Progression

Autocrine Complement Inhibits IL10-Dependent T-Cell Mediated. Antitumor Immunity to Promote Tumor Progression Supplemental Information Autocrine Complement Inhibits IL10-Dependent T-Cell Mediated Antitumor Immunity to Promote Tumor Progression Yu Wang, Sheng-Nan Sun, Qing Liu, Yang-Yang Yu, Jian Guo, Kun Wang,

More information

01/08/2018. Control of Microbial Growth. Methods. Terminology. Disinfectants and Antiseptics. Three approaches. Cleaning. Chemical.

01/08/2018. Control of Microbial Growth. Methods. Terminology. Disinfectants and Antiseptics. Three approaches. Cleaning. Chemical. Control of Microbial Growth Disinfectants and Antiseptics 1 Methods 2 Three approaches Chemical Disinfectants and antiseptics Physical Heat Ultraviolet Irradiations Mechanical elimination Cleaning Filtration

More information

Development of NOG mice

Development of NOG mice Development of NOG mice General characteris5cs of NOG mice 1. T and B cell deficient 2. NK cell deficient 3. Reduced macrophage and dendri;c cell func;on 4. Complement ac;vity deficient 5. No incidence

More information

THE EFFECT OF ANTISERUM FRACTIONS ON EHRLICH ASCITES TUMOUR CELLS

THE EFFECT OF ANTISERUM FRACTIONS ON EHRLICH ASCITES TUMOUR CELLS 315 THE EFFECT OF ANTISERUM FRACTIONS ON EHRLICH ASCITES TUMOUR CELLS MILDRED WANG* From the Department of Veterinary Microbiology and Immunology, University of Guelph, Guelph, Ontario, Canada Received

More information

EFFECT OF THE SIZE OF INOCULUM ON THE GROWTH OF TRANSPLANTABLE RAT TUMORS 1

EFFECT OF THE SIZE OF INOCULUM ON THE GROWTH OF TRANSPLANTABLE RAT TUMORS 1 EFFECT OF THE SIZE OF INOCULUM ON THE GROWTH OF TRANSPLANTABLE RAT TUMORS 1 ROBERT SCHREK, M.D. (From the Department 01 Pathology, Vanderbilt University School 01 Medicine, Nashville, Tennessee) A knowledge

More information

A New Killer Factor Produced by a Killer/Sensitive Yeast Strain

A New Killer Factor Produced by a Killer/Sensitive Yeast Strain Journal of General Microbiology (1974), 81,285-289 Printed in-great Britain A New Killer Factor Produced by a Killer/Sensitive Yeast Strain By D. R. WOODS, I. W. ROSS AND D.A. HENDRY Department of Botany

More information

Cells Culture Techniques Marta Czernik

Cells Culture Techniques Marta Czernik Cells Culture Techniques 13.03.2018 Marta Czernik Why we need the cell/tissue culture Research To overcome problems in studying cellular behaviour such as: - confounding effects of the surrounding tissues

More information

Screening of Anticancer Materials from Myxobacteria and Evaluation of Their Bioactivity in Vivo

Screening of Anticancer Materials from Myxobacteria and Evaluation of Their Bioactivity in Vivo Screening of Anticancer Materials from Myxobacteria and Evaluation of Their Bioactivity in Vivo Jia Hong Key Lab of Microbial Diversity Research and Application of Hebei Province College of Life Sciences,

More information

Grouping of Feline Calicivirus Field Isolates Using Monoclonal Antibodies

Grouping of Feline Calicivirus Field Isolates Using Monoclonal Antibodies SHORT REPORT Grouping of Feline Calicivirus Field Isolates Using Monoclonal Antibodies Tomoko TAJIMA, Erika NAKATA, Yukinobu TOHYAI1), Kazuyo YURI2), Hiromi KATAE2), and Takeshi MIKAMI3) Department of

More information

Supplementary figures

Supplementary figures Mucida et al. Supplementary material Supplementary figures Supplementary Figure 1. Oral administration of OVA suppresses Th2 differentiation, Germinal Center (GC) formation and immunoglobulin class switching

More information

Stem Cel s Key Words:

Stem Cel s Key Words: Stem Cells Key Words: Embryonic stem cells, Adult stem cells, ips cells, self-renewal, differentiation, pluripotent, multipotent, Inner cell mass, Nuclear transfer (Therapeutic cloning), Feeder cells,

More information

Xeno-Free Systems for hesc & hipsc. Facilitating the shift from Stem Cell Research to Clinical Applications

Xeno-Free Systems for hesc & hipsc. Facilitating the shift from Stem Cell Research to Clinical Applications Xeno-Free Systems for hesc & hipsc Facilitating the shift from Stem Cell Research to Clinical Applications NutriStem Defined, xeno-free (XF), serum-free media (SFM) specially formulated for growth and

More information

Solutions for Your Research

Solutions for Your Research Solutions for Your Research Custom Antibody Services Polyclonal Monoclonal The service we offer is very complete starting from rabbits, mice and rats. The different formats provided by Primm depend on

More information

Data Sheet CD137/NF-κB Reporter - HEK293 Recombinant Cell Line Catalog # 79289

Data Sheet CD137/NF-κB Reporter - HEK293 Recombinant Cell Line Catalog # 79289 Data Sheet CD137/NF-κB Reporter - HEK293 Recombinant Cell Line Catalog # 79289 Background Human CD137 (4-1BB; TNFRS9) is an inducible co-stimulatory molecule that activates T cells. CD137:CD137L-mediated

More information

Specific Immune Response Against Tumor-Associated of a Syngeneic Simian Virus 40-lnduced Sarcoma in

Specific Immune Response Against Tumor-Associated of a Syngeneic Simian Virus 40-lnduced Sarcoma in Specific Immune Response Against Tumor-Associated of a Syngeneic Simian Virus 40-lnduced Sarcoma in Antigens Mice 1 Moshe Glaser 2, 3 ABSTRACT-Immune response against syngeneic simian virus 40 (SV40)-lnduced

More information

Gene Technology classification of dealings involving self-inactivating, replication defective, retroviral vectors.

Gene Technology classification of dealings involving self-inactivating, replication defective, retroviral vectors. Gene Technology classification of dealings involving self-inactivating, replication defective, retroviral vectors. The use of replication defective, retroviral vectors for research purposes has become

More information

North American Ginseng & Auricularia sp. mushroom aq. extract have beneficial effect on cyclophosphamide induced immunosuppression in mice

North American Ginseng & Auricularia sp. mushroom aq. extract have beneficial effect on cyclophosphamide induced immunosuppression in mice North American Ginseng & Auricularia sp. mushroom aq. extract have beneficial effect on cyclophosphamide induced immunosuppression in mice Kyakulaga A. Hassan, Ed Lui OGIRC Journal club, October 2012 Department

More information

For in vitro killing assays with lysed cells, neutrophils were sonicated using a 550 Sonic

For in vitro killing assays with lysed cells, neutrophils were sonicated using a 550 Sonic Supplemental Information Cell Host & Microbe, Volume 8 Statins Enhance Formation of Phagocyte Extracellular Traps Ohn A. Chow, Maren von Köckritz-Blickwede, A. Taylor Bright, Mary E. Hensler, Annelies

More information

PASSIVE PROTECTION BY HUMAN SERUM IN MICE INFECTED WITH ENCAPSULATED STAPHYLOCOCCUS A UREUS

PASSIVE PROTECTION BY HUMAN SERUM IN MICE INFECTED WITH ENCAPSULATED STAPHYLOCOCCUS A UREUS PASSIVE PROTECTION BY HUMAN SERUM IN MICE INFECTED WITH ENCAPSULATED STAPHYLOCOCCUS A UREUS K. YOSHIDA, Y. ICHIMAN, S. NARIKAWA, M. TAKAHASHI, E. KONO* AND C. L. SAN CLEMENTE? Department of Microbiology

More information

TITLE: A Fusogenic Oncolytic Herpes Simplex Virus for Therapy of Advanced Ovarian Cancer

TITLE: A Fusogenic Oncolytic Herpes Simplex Virus for Therapy of Advanced Ovarian Cancer AD Award Number: DAMD17-03-1-0434 TITLE: A Fusogenic Oncolytic Herpes Simplex Virus for Therapy of Advanced Ovarian Cancer PRINCIPAL INVESTIGATOR: Xiaoliu Zhang, M.D., Ph.D. CONTRACTING ORGANIZATION: Baylor

More information

Investigations in Immune Suppression for Monoclonal Antibody Therapeutics

Investigations in Immune Suppression for Monoclonal Antibody Therapeutics Investigations in Immune Suppression for Monoclonal Antibody Therapeutics Vibha Jawa Principal Scientist AAPS NBC Meeting, May 2016 Clinical Immunology, Medical Sciences, Amgen Background Therapeutic proteins

More information

Dextran Sulphate 500 Delays and Prevents Mouse Scrapie by Impairment of Agent Replication in Spleen

Dextran Sulphate 500 Delays and Prevents Mouse Scrapie by Impairment of Agent Replication in Spleen J. gen. Virol. (1984), 65, 1325-1330. Printed in Great Britain 1325 Key words: scrapie/dextran sulphate/pathogenesis Dextran Sulphate 500 Delays and Prevents Mouse Scrapie by Impairment of Agent Replication

More information

Human IFN-γ. Pre-Coated ELISA Kit

Human IFN-γ. Pre-Coated ELISA Kit Human IFN-γ (Interferon Gamma) Pre-Coated ELISA Kit Catalog No: 90-2067 1 96 well Format (96 tests) Detection Range: 15.6 1000 pg/ml Sensitivity: < 9.4 pg/ml This immunoassay kit allows for the in vitro

More information

Alternatives to In-Vivo Testing for Animal Biologics: North American Regulatory Perspective

Alternatives to In-Vivo Testing for Animal Biologics: North American Regulatory Perspective Alternatives to In-Vivo Testing for Animal Biologics: North American Regulatory Perspective Geetha B. Srinivas, DVM, PhD Section Leader, Virology Center for Veterinary Biologics USDA/APHIS/VS IABS 2018,

More information

Experimental models for lead optimisation of novel antileishmanial agents Sunil Puri, PhD

Experimental models for lead optimisation of novel antileishmanial agents Sunil Puri, PhD Experimental models for lead optimisation of novel antileishmanial agents Sunil Puri, PhD Central Drug Research Institute Lucknow, India Experimental Models for Lead Identification of Novel Antileishmanial

More information

Mid-term review. Recitation5 03/31/2014. Stem Cell Biology and Function W4193 1

Mid-term review. Recitation5 03/31/2014. Stem Cell Biology and Function W4193 1 Mid-term review Recitation5 03/31/2014 Stem Cell Biology and Function W4193 1 What to expect in the midterm2 It will be all so far but mainly whatever was NOT covered by the previous mid-term- not a huge

More information

RXi Pharmaceuticals. BioPharm America September 26, 2017 NASDAQ: RXII. Property of RXi Pharmaceuticals

RXi Pharmaceuticals. BioPharm America September 26, 2017 NASDAQ: RXII. Property of RXi Pharmaceuticals RXi Pharmaceuticals BioPharm America September 26, 2017 NASDAQ: RXII Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation

More information

Gene Technology classification of dealings involving self-inactivating, replication defective, retroviral vectors.

Gene Technology classification of dealings involving self-inactivating, replication defective, retroviral vectors. Gene Technology classification of dealings involving self-inactivating, replication defective, retroviral vectors. The use of replication defective, retroviral vectors for research purposes has become

More information

York University School of Medicine, NY. Bhagavathi A. Narayanan, PhD 1, Caroline Cunnigham 1 and Amitabha Mazumder, MD 2. Title

York University School of Medicine, NY. Bhagavathi A. Narayanan, PhD 1, Caroline Cunnigham 1 and Amitabha Mazumder, MD 2. Title Title Suppression of Human Multiple Myeloma Cell Growth by TBL-12 in Combination with low doses of Velcade: Insight in to the modulation of IL-6/STAT-3 mechanisms Bhagavathi A. Narayanan, PhD 1, Caroline

More information

Retinoic acid (vitamin A acid) induced transcriptional control

Retinoic acid (vitamin A acid) induced transcriptional control Proc. Natl. Acad. Sci. USA Vol. 74, No. 12, pp. 5382-5386, December 1977 Biochemistry Retinoic acid (vitamin A acid) induced transcriptional control of interferon production [cycloheximide/l-929 cells/poly(ri)poly(rc)/newcastle

More information

Replication of Vesicular Stomatitis Virus Facilitated by Shope

Replication of Vesicular Stomatitis Virus Facilitated by Shope INFECTION AND IMMUNITY, July 1979, p. 213-219 0019-9567/79/07-0213/07 $02.00/0 Vol. 25, No. 1 Replication of Vesicular Stomatitis Virus Facilitated by Shope Fibroma Virus In Vivo NORMAN A. CROUCHt* AND

More information

Developing Targeted Stem Cell Therapeutics for Cancer. Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013

Developing Targeted Stem Cell Therapeutics for Cancer. Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013 Developing Targeted Stem Cell Therapeutics for Cancer Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013 The Challenge of Drug Delivery for Brain Cancer Stem Cells

More information

ICH Considerations Oncolytic Viruses ONCOLYTIC VIRUSES (EMEA/CHMP/ICH/607698/2008) TRANSMISSION TO CHMP November 2008

ICH Considerations Oncolytic Viruses ONCOLYTIC VIRUSES (EMEA/CHMP/ICH/607698/2008) TRANSMISSION TO CHMP November 2008 European Medicines Agency October 2009 EMEA/CHMP/ICH/607698/2008 ICH Considerations Oncolytic Viruses ONCOLYTIC VIRUSES (EMEA/CHMP/ICH/607698/2008) TRANSMISSION TO CHMP November 2008 TRANSMISSION TO INTERESTED

More information

Gene therapy has gained significant attention over the past two decades as a potential method for treating genetic disorders such as severe combined

Gene therapy has gained significant attention over the past two decades as a potential method for treating genetic disorders such as severe combined Abstract Gene therapy has gained significant attention over the past two decades as a potential method for treating genetic disorders such as severe combined immunodeficiency, cystic fibrosis, and Parkinson

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer P. H. Lizotte, A. M. Wen, M. R. Sheen, J. Fields, P. Rojanasopondist, N. F. Steinmetz, S. Fiering Supplementary Information

More information

Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology

Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology Chapter 17: Immunization & Immune Testing 1. Immunization 2. Diagnostic Immunology 1. Immunization Chapter Reading pp. 505-511 What is Immunization? A method of inducing artificial immunity by exposing

More information

1. Immunization. What is Immunization? 12/9/2016. Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology

1. Immunization. What is Immunization? 12/9/2016. Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology Chapter 17: Immunization & Immune Testing 1. Immunization 2. Diagnostic Immunology 1. Immunization Chapter Reading pp. 505-511 What is Immunization? A method of inducing artificial immunity by exposing

More information

Recombinant, Insect Cell-Derived RSV Nanoparticle Vaccine

Recombinant, Insect Cell-Derived RSV Nanoparticle Vaccine Recombinant, Insect Cell-Derived RSV Nanoparticle Vaccine Gregory Glenn Chief Medical Officer MVADS-Copenhagen 4 July 2012 1 Agenda for RSV Discussion Overview of Insect Cell Technology Respiratory Syncytial

More information

Human GM-CSF ELISA Kit

Human GM-CSF ELISA Kit Human GM-CSF ELISA Kit CATALOG NO: IRKTAH3050 LOT NO: SAMPLE INTENDED USE For quantitative detection of human GM-CSF in cell culture supernates, serum and plasma (heparin, EDTA, citrate). BACKGROUND Granulocyte-macrophage

More information

Rabbit Anti-Mouse/Rat Asialo GM1 Polyclonal Antibody

Rabbit Anti-Mouse/Rat Asialo GM1 Polyclonal Antibody Rabbit Anti-Mouse/Rat Asialo GM1 Polyclonal Antibody CL8955 LOT: KQF6371 DESCRIPTION: Cedarlane s Anti-Asialo GM1 polyclonal antibody reacts with mouse and rat Natural Killer (NK) cells. It also exhibits

More information

MCB 4211, Fall 2018, Practice Exam 1 Last, First name Student ID # Seat No. ***NOTE: Exam will have 40 multiple choice questions.

MCB 4211, Fall 2018, Practice Exam 1 Last, First name Student ID # Seat No. ***NOTE: Exam will have 40 multiple choice questions. MCB 4211, Fall 2018, Practice Exam 1 Last, First name Student ID # Seat No. ***NOTE: Exam 1 2018 will have 40 multiple choice questions. READ ALL THE CHOICES AND SELECT THE BEST 1. Which of the following

More information

a. Hypoxanthine was present in the media. MCB 4211, Fall 2018, Practice Exam 1 Last, First name Student ID # Seat No.

a. Hypoxanthine was present in the media. MCB 4211, Fall 2018, Practice Exam 1 Last, First name Student ID # Seat No. MCB 4211, Fall 2018, Practice Exam 1 Last, First name Student ID # Seat No. ***NOTE: Exam 1 2018 will have 40 multiple choice questions. READ ALL THE CHOICES AND SELECT THE BEST 1. Which of the following

More information

Outline. o Immunogenicity of therapeutic protein aggregates. o Clinical evidence. o Models to study the immunogenicity of aggregates

Outline. o Immunogenicity of therapeutic protein aggregates. o Clinical evidence. o Models to study the immunogenicity of aggregates Immunogenicity of Therapeutic Protein Aggregates Ehab Moussa 11-14-2016 Outline o Immunogenicity of therapeutic protein aggregates o Clinical evidence o Models to study the immunogenicity of aggregates

More information

Supplemental Information Inventory

Supplemental Information Inventory Cell Stem Cell, Volume 6 Supplemental Information Distinct Hematopoietic Stem Cell Subtypes Are Differentially Regulated by TGF-β1 Grant A. Challen, Nathan C. Boles, Stuart M. Chambers, and Margaret A.

More information

Data Sheet HVEM/NF-κB Reporter Jurkat Recombinant Cell Line Catalog # 79310

Data Sheet HVEM/NF-κB Reporter Jurkat Recombinant Cell Line Catalog # 79310 Data Sheet HVEM/NF-κB Reporter Jurkat Recombinant Cell Line Catalog # 79310 Product Description Recombinant clonal stable Jurkat T cell line expressing firefly luciferase gene under the control of 4 copies

More information

Tumor-infiltrating dendritic cells suppress nucleic acid-mediated. innate immune responses through TIM-3-HMGB1 interactions

Tumor-infiltrating dendritic cells suppress nucleic acid-mediated. innate immune responses through TIM-3-HMGB1 interactions SUPPLEMENTARY INFORMATION 8 Supplementary figures Tumor-infiltrating dendritic cells suppress nucleic acid-mediated innate immune responses through -HMG1 interactions Shigeki Chiba 1, Muhammad aghdadi

More information

Rabies Potency Testing

Rabies Potency Testing www.pei.de Rabies Potency Testing Regulatory Perspectives and Experiences in the Establishment of a Serological Assay Dr Constanze Goepfert Section Viral Vaccines Laboratory Head Das Paul-Ehrlich-Institut

More information

Antibodies to Animal Cells and Serum Proteins

Antibodies to Animal Cells and Serum Proteins ANTIBODIES TO ANIMAL CELLS AND SERUM PROTEINS Antibodies to Animal Cells and Serum Proteins Antibodies to Animal Cellular Antigens Antibodies to Mouse Brain Antibodies to Animal Serum Proteins INTERNATIONAL

More information

Mouse Strain Resistant to N-, B-, and NB-Tropic Murine Leukemia Viruses

Mouse Strain Resistant to N-, B-, and NB-Tropic Murine Leukemia Viruses JOURNAL OF VIROLoGY, Nov. 1976, p. 436-440 Copyright 1976 American Society for Microbiology Vol. 20, No. 2 Printed in U.S.A. Mouse Strain Resistant to N-, B-, and NB-Tropic Murine Leukemia Viruses KAZUSHIGE

More information

Purification of Host DNA Synthesis-Suppressing Factor (DSF) Produced by Infection with Measles Virus

Purification of Host DNA Synthesis-Suppressing Factor (DSF) Produced by Infection with Measles Virus Japan. J. Microbiol. Vol. 20 (6), 499-505, 1976 Purification of Host DNA Synthesis-Suppressing Factor (DSF) Produced by Infection with Measles Virus Tomoko K. YAMAMOTO1, Tomonori MINAGAWA, and Hiroo IIDA

More information

The RT-qPCR analysis of selected type-i IFNs related genes, IRF7 and Oas3. The

The RT-qPCR analysis of selected type-i IFNs related genes, IRF7 and Oas3. The SUPPLEMENTARY MATERIALS AND METHODS Real time quantitative PCR The RT-qPCR analysis of selected type-i IFNs related genes, IRF7 and Oas3. The RT-qPCR was performed on the Applied Biosystems StepOne TM

More information

Linker p. 177 Helper Lipid p. 178 Delivery to Target Cells p. 180 Cell Entry p. 182 Receptor-Mediated Uptake p. 182 Endosomai Release p.

Linker p. 177 Helper Lipid p. 178 Delivery to Target Cells p. 180 Cell Entry p. 182 Receptor-Mediated Uptake p. 182 Endosomai Release p. Overview of Regulatory Expectations for Introducing Novel Therapies into Clinical Trials Introduction p. 1 Roles of Regulatory Scientists p. 2 Product Development and Availability p. 2 Data Requirements

More information

Supplemental methods:

Supplemental methods: Supplemental methods: ASC-J9 treatment ASC-J9 was patented by the University of Rochester, the University of North Carolina, and AndroScience Corp., and then licensed to AndroScience Corp. Both the University

More information

Activation of Mouse Peritoneal Cells to Kill Listeria

Activation of Mouse Peritoneal Cells to Kill Listeria INFEcTION AND IMMUNITY, JUlY 1975, p. 36-41 Copyright 0 1975 American Society for Microbiology Vol. 12, No. 1 Printed in U.S.A. Activation of Mouse Peritoneal Cells to Kill Listeria monocytogenes by T-Lymphocyte

More information

Modulation of Immune Response in Lambs

Modulation of Immune Response in Lambs Modulation of Immune Response in Lambs A.S. Leaflet R1473 Jose O. Lopez Virella, graduate research assistant, M. L. Kaeberle, professor, veterinary microbiology Mamadou Niang, graduate research assistant.

More information

c) Assuming he does not run another endurance race, will the steady-state populations be affected one year later? If so, explain how.

c) Assuming he does not run another endurance race, will the steady-state populations be affected one year later? If so, explain how. LS1a Fall 06 Problem Set #8 (100 points total) all questions including the (*extra*) one should be turned in 1. (18 points) Erythrocytes, mature red blood cells, are essential for transporting oxygen to

More information

AN EXAMINATION OF THE EFFECTS OF SIMVASTATIN ON INNATE IMMUNE RESPONSES TO S. AUREUS A RESEARCH PAPER BY TRACI STANKIEWICZ

AN EXAMINATION OF THE EFFECTS OF SIMVASTATIN ON INNATE IMMUNE RESPONSES TO S. AUREUS A RESEARCH PAPER BY TRACI STANKIEWICZ AN EXAMINATION OF THE EFFECTS OF SIMVASTATIN ON INNATE IMMUNE RESPONSES TO S. AUREUS A RESEARCH PAPER BY TRACI STANKIEWICZ SUBMITTED TO THE GRADUATE SCHOOL IN PARTIAL FULFILLMENT OF THE REQUIRMENTS SET

More information

Protocol for induction of expression and cell lysate production

Protocol for induction of expression and cell lysate production Protocol for induction of expression and cell lysate production AV-04 Doxycyclin induction and cell lysate 1.0 Introduction / Description This method is intended for the treatment of the previously transfected

More information

Examination in Immunotechnology, 30 May 2011, 8-13

Examination in Immunotechnology, 30 May 2011, 8-13 Examination in Immunotechnology, 30 May 2011, 8-13 1 Each question can give 5p, with a total of 10 questions (i.e. 50 points in total). 2 Write name and personal number on ALL pages (including the cover).

More information

Supplemental Information

Supplemental Information Supplemental Information DLA-matched bone marrow transplantation reverses the immunodeficiency of SCID dogs. Bone marrow transplantation studies were initiated with the goal of reversing the immunodeficiency

More information

Nanogel-Based Immunologically Stealth Vaccine Targets Macrophages in the Medulla of Lymph Node and Induces Potent Antitumor Immunity

Nanogel-Based Immunologically Stealth Vaccine Targets Macrophages in the Medulla of Lymph Node and Induces Potent Antitumor Immunity Nanogel-Based Immunologically Stealth Vaccine Targets Macrophages in the Medulla of Lymph Node and Induces Potent Antitumor Immunity Daisuke Muraoka, Naozumi Harada,, Tae Hayashi, Yoshiro Tahara,, Fumiyasu

More information

Data Sheet. Glucocorticoid Receptor Pathway GAL4 Reporter (Luc)-HEK293 cell Line Catalog #: w70666

Data Sheet. Glucocorticoid Receptor Pathway GAL4 Reporter (Luc)-HEK293 cell Line Catalog #: w70666 Data Sheet Glucocorticoid Receptor Pathway GAL4 Reporter (Luc)-HEK293 cell Line Catalog #: w70666 Background The glucocorticoid signaling pathway plays an important role in development, fluid homeostasis,

More information

Purification of a Novel Growth Inhibitory Factor for Partially Differentiated Myeloid Leukemic Cells*

Purification of a Novel Growth Inhibitory Factor for Partially Differentiated Myeloid Leukemic Cells* THE JOURNAL OF BIOLOGICAL CHEMISTRY D 1988 by The American Society for Biochemistry and Molecular Biology, lne. Vol.263, No. 11, Issue of April 15, pp. 5431-5435, 1988 Printed in U.S.A. Purification of

More information

Data Sheet. MAPK/ERK Signaling Pathway SRE Reporter HEK293 Cell Line Catalog #: 60406

Data Sheet. MAPK/ERK Signaling Pathway SRE Reporter HEK293 Cell Line Catalog #: 60406 Data Sheet MAPK/ERK Signaling Pathway SRE Reporter HEK293 Cell Line Catalog #: 60406 Description The MAPK/ERK signaling pathway is a major participant in the regulation of cell growth and differentiation.

More information

Apoptosis And Anti-tumor Effect Induced By Mtor Inhibitor And Autophagy Inhibitor In Human Osteosarcoma Cells

Apoptosis And Anti-tumor Effect Induced By Mtor Inhibitor And Autophagy Inhibitor In Human Osteosarcoma Cells Apoptosis And Anti-tumor Effect Induced By Mtor Inhibitor And Autophagy Inhibitor In Human Osteosarcoma Cells Ryosuke Horie. Kagawa University of medecine, Kita-gun, Japan. Disclosures: R. Horie: None.

More information

CHAPTER 7 CELLULAR BASIS OF ANTIBODY DIVERSITY: CLONAL SELECTION

CHAPTER 7 CELLULAR BASIS OF ANTIBODY DIVERSITY: CLONAL SELECTION CHAPTER 7 CELLULAR BASIS OF ANTIBODY DIVERSITY: CLONAL SELECTION The specificity of humoral immune responses relies on the huge DIVERSITY of antigen combining sites present in antibodies, diversity which

More information

Page 1 of 5. Product Name Label Quantity Product No. Cy 3 10 µg (~0.75 nmol) MIR Cy µg (~7.5 nmol) MIR 7901

Page 1 of 5. Product Name Label Quantity Product No. Cy 3 10 µg (~0.75 nmol) MIR Cy µg (~7.5 nmol) MIR 7901 Page 1 of 5 Label IT RNAi Delivery Control Product Name Label Quantity Product No. Cy 3 10 µg (~0.75 nmol) MIR 7900 Label IT RNAi Delivery Control Cy 3 100 µg (~7.5 nmol) MIR 7901 Fluorescein 10 µg (~0.75

More information

Data Sheet. Glucocorticoid Receptor Pathway GR-GAL4 Reporter (Luc)-HEK293 cell Line Catalog #: 60655

Data Sheet. Glucocorticoid Receptor Pathway GR-GAL4 Reporter (Luc)-HEK293 cell Line Catalog #: 60655 Data Sheet Glucocorticoid Receptor Pathway GR-GAL4 Reporter (Luc)-HEK293 cell Line Catalog #: 60655 Background The glucocorticoid signaling pathway plays an important role in development, fluid homeostasis,

More information

Midori Green Advance DNA Stain Safety Report

Midori Green Advance DNA Stain Safety Report Publishing date: 30.09.2011 Midori Green Advance DNA Stain Safety Report IDENTIFICATION OF THE PRODUCT AND OF THE COMPANY Product name Catalog number Supplier Information in case of emergency Midori Green

More information

Inhibition of Herpesvirus hominis Replication by Human Interferon

Inhibition of Herpesvirus hominis Replication by Human Interferon INFECTION AND IMMUNITY, July 1975, p. 104-108 Copyright 0 1975 American Society for Microbiology Vol. 12, No. 1 Printed in U.S.A. Inhibition of Herpesvirus hominis Replication by Human Interferon LUCY

More information

those obtained from tissues or intact animals. spleen tissue cultures were exposed to LPS at 230C, an early product produced after 24 h of

those obtained from tissues or intact animals. spleen tissue cultures were exposed to LPS at 230C, an early product produced after 24 h of INFECTION AND IMMUNITY, Jan. 1977, P. 78-83 Copyright 1977 American Society for Microbiology Vol. 15, No. 1 Printed in U.S.A. Cellular Origin of Interferon Induced by Bacterial Lipopolysaccharide NOBUTOSHI

More information

DepoVax TM : A novel delivery formulation for cancer immunotherapy and infectious disease vaccines

DepoVax TM : A novel delivery formulation for cancer immunotherapy and infectious disease vaccines DepoVax TM : A novel delivery formulation for cancer immunotherapy and infectious disease vaccines May 10, 2017 The DepoVax Platform A patented oil-based formulation NOT an adjuvant Creates powerful vaccines

More information

Implications of TL Phenotype Changes in an H-2-Loss Variant of a Transplanted H-2b/H-2a Leukemia*

Implications of TL Phenotype Changes in an H-2-Loss Variant of a Transplanted H-2b/H-2a Leukemia* Proceedings of the National Academy of Sciences Vol. 65, No. 4, pp. 933-938, April 1970 Implications of TL Phenotype Changes in an H-2-Loss Variant of a Transplanted H-2b/H-2a Leukemia* Edward A. Boyse,

More information

Immunogenicity of Therapeutic Proteins. Steven J Swanson, Ph.D. Executive Director, Clinical Immunology

Immunogenicity of Therapeutic Proteins. Steven J Swanson, Ph.D. Executive Director, Clinical Immunology Immunogenicity of Therapeutic Proteins Steven J Swanson, Ph.D. Executive Director, Clinical Immunology swanson@amgen.com Causes of Immunogenicity Sequence differences between therapeutic protein and endogenous

More information

Required Materials. Stemgent Reprogramming-Qualified Nuff Cells GSC-3006G 4 x 10 6 cells/vial Liquid Nitrogen

Required Materials. Stemgent Reprogramming-Qualified Nuff Cells GSC-3006G 4 x 10 6 cells/vial Liquid Nitrogen Page 1 Overview This protocol for microrna-enhanced mrna reprogramming describes the combined use of the Stemgent mrna Reprogramming Kit, the Stemgent microrna Booster Kit, and the Stemfect RNA Transfection

More information

TUMOUR-NECROSIS FACTOR FROM THE RABBIT. V. SYNTHESIS

TUMOUR-NECROSIS FACTOR FROM THE RABBIT. V. SYNTHESIS Br. J. Cancer (1981) 44, 418 TUMOUR-NECROSIS FACTOR FROM THE RABBIT. V. SYNTHESIS IN VITRO BY MONONUCLEAR PHAGOCYTES FROM VARIOUS TISSUES OF NORMAL AND BCG-INJECTED RABBITS N. MATTHEWS From the Department

More information